8EQ0
Escherichia coli pyruvate kinase G381A
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX1 |
Synchrotron site | Australian Synchrotron |
Beamline | MX1 |
Temperature [K] | 110 |
Detector technology | CCD |
Collection date | 2012-10-12 |
Detector | ADSC QUANTUM 210r |
Wavelength(s) | 0.9537 |
Spacegroup name | C 2 2 21 |
Unit cell lengths | 74.513, 247.045, 130.231 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 48.090 - 2.620 |
R-factor | 0.2039 |
Rwork | 0.202 |
R-free | 0.23350 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4yng |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | PHENIX (1.19.2_4158) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 48.090 | 2.716 |
High resolution limit [Å] | 2.620 | 2.620 |
Rmerge | 0.191 | |
Number of reflections | 35719 | 2799 |
<I/σ(I)> | 7.11 | 1.78 |
Completeness [%] | 97.8 | |
Redundancy | 7.3 | |
CC(1/2) | 0.991 | 0.515 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 293 | 0.1M (0.2M DL-Glutamic acid monohydrate; 0.2M DL-Alanine; 0.2M Glycine; 0.2M DL-Lysine monohydrochloride; 0.2M DL-Serine), 0.1M (1.0M Sodium HEPES; 1.0M MOPS (acid)), 30% v/v (40% v/v Glycerol; 20% w/v PEG 4000) |